fluoxetine and gabapentin

fluoxetine has been researched along with gabapentin in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (9.68)	18.2507
2000's	10 (32.26)	29.6817
2010's	16 (51.61)	24.3611
2020's	2 (6.45)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Aharoni, A; Geffen, Y; Gil-Ad, I; Halbfinger, E; Nisemblat, Y; Nudelman, A; Rephaeli, A; Tarasenko, I; Tarasenko, N; Weizman, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Choi, Y; Raymer, BK	1
Corá-Locatelli, G; Greenberg, BD; Martin, JD; Murphy, DL	1
Matthews, J; Pollack, MH; Scott, EL	1
Corá-Locatelli, G; Greenberg, BD; Martin, J; Murphy, DL	1
Churchill, LE; Connor, KM; Davidson, JR; Foa, EB	1
Chan, W; Yen, HL	1
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY	1
Blackburn-Munro, G; Nielsen, AN; Pedersen, LH	1
Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS	1
Alexander, IM; Moore, A	1
Gökbakan, M; Onder, E; Tural, U	1
MacGregor, EA	1
Bain, MJ; Fan, CM	1
Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K	1
Denenberg, S	1
Oflaz, S; Soyata, AZ	1
Ghorbani, R; Mohseni, A; Rahmanian, M	1
Orlando, JM	2
Alikhani, M; Almasi, A; Brand, S; Davarinejad, O; Farnia, V; Gharehbaghi, H; Golshani, S; Holsboer-Trachsler, E; Sadeghi Bahmani, D; Salemi, S; Tatari, F	1
Calder, CD	1
Chen, KY; Li, RY	1
Ali, G; Alkahramaan, YMSA; Arif, M; Gohar, A; Khan, MS; Rashid, U; Rauf, K; Sewell, RDE	1

Reviews

5 review(s) available for fluoxetine and gabapentin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Sleep modulating agents. Bioorganic & medicinal chemistry letters, 2019, 08-15, Volume: 29, Issue:16 Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents	2019
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective. Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:3 Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors	2007
Perimenopausal migraine in women with vasomotor symptoms. Maturitas, 2012, Volume: 71, Issue:1 Topics: Amines; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Migraine Disorders; Neurotransmitter Agents; Perimenopause	2012
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review. PloS one, 2022, Volume: 17, Issue:10 Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins	2022

Trials

4 trial(s) available for fluoxetine and gabapentin

Article	Year
Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:9 Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Obsessive-Compulsive Disorder; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1998
Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder? European archives of psychiatry and clinical neuroscience, 2008, Volume: 258, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Amines; Analysis of Variance; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2008
A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2015, Volume: 131, Issue:1 Topics: Amines; Cross-Over Studies; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Iran; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Sweating; Treatment Outcome	2015
Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial. Journal of psychiatric research, 2018, Volume: 104 Topics: Adult; Anticonvulsants; Dopamine Agents; Double-Blind Method; Female; Fluoxetine; Gabapentin; Humans; Male; Memantine; Obsessive-Compulsive Disorder; Outpatients; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2018

Other Studies

22 other study(ies) available for fluoxetine and gabapentin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity. Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9 Topics: Analgesics; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Fluoxetine; Formaldehyde; gamma-Aminobutyric Acid; Inflammation; Male; Mice; Nortriptyline; Pain; Rats	2009
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Rebound psychiatric and physical symptoms after gabapentin discontinuation. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:3 Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Obsessive-Compulsive Disorder; Recurrence; Substance Withdrawal Syndrome	1998
Gabapentin as a potential treatment for anxiety disorders. The American journal of psychiatry, 1998, Volume: 155, Issue:7 Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders	1998
Treating hot flashes with drugs: an update. Harvard women's health watch, 2002, Volume: 9, Issue:12 Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride	2002
Hyperhidrosis in social anxiety disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:7-8 Topics: Acetates; Adult; Amines; Calcium Channel Blockers; Clinical Trials as Topic; Clonazepam; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Female; Fluoxetine; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperhidrosis; Male; Phobic Disorders; Prognosis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors	2002
An East-West approach to the management of central post-stroke pain. Cerebrovascular diseases (Basel, Switzerland), 2003, Volume: 16, Issue:1 Topics: Acetates; Acupuncture; Aged; Amines; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol; Triazines	2003
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2 Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride	2004
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology, 2005, Volume: 182, Issue:4 Topics: Amines; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Constriction; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Male; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reboxetine; Rotarod Performance Test; Spinal Cord Injuries; Vesicular Monoamine Transport Proteins	2005
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus. Neuroscience letters, 2006, Nov-13, Volume: 408, Issue:2 Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Pimozide; Rats; Seizures; Status Epilepticus	2006
Animal behavior case of the month. Motivation for the tail-chasing behavior was considered to most likely be multifactorial. Journal of the American Veterinary Medical Association, 2012, Mar-15, Volume: 240, Issue:6 Topics: Acepromazine; Amines; Animals; Anticonvulsants; Behavior, Animal; Compulsive Behavior; Cyclohexanecarboxylic Acids; Displacement, Psychological; Dog Diseases; Dogs; Dopamine Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Selective Serotonin Reuptake Inhibitors	2012
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:8 Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride	2012
Animal behavior case of the month. Tail chasing in a dog diagnosed as compulsive disorder. Journal of the American Veterinary Medical Association, 2015, May-01, Volume: 246, Issue:9 Topics: Amines; Animals; Anticonvulsants; Behavior, Animal; Bites and Stings; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Tail	2015
Gabapentin Treatment in Bruxism Associated With Fluoxetine. Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:4 Topics: Adult; Amines; Bruxism; Cyclohexanecarboxylic Acids; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2015
Animal Behavior Case of the Month. Journal of the American Veterinary Medical Association, 2017, 11-01, Volume: 251, Issue:9 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diazepam; Dog Diseases; Dogs; Fear; Fluoxetine; Gabapentin; Male; Noise; Paroxetine; Phobic Disorders	2017
Animal Behavior Case of the Month. Journal of the American Veterinary Medical Association, 2018, 01-01, Volume: 252, Issue:1 Topics: Animals; Anti-Anxiety Agents; Behavior Therapy; Behavior, Animal; Compulsive Behavior; Dog Diseases; Dogs; Female; Fluoxetine; Gabapentin; Selective Serotonin Reuptake Inhibitors	2018
Animal Behavior Case of the Month. Journal of the American Veterinary Medical Association, 2019, Jan-15, Volume: 254, Issue:2 Topics: Aggression; Animals; Anti-Anxiety Agents; Behavior Therapy; Behavior, Animal; Dogs; Environment; Fear; Fluoxetine; Gabapentin; Male; Selective Serotonin Reuptake Inhibitors; Trazodone	2019
Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition. Drug design, development and therapy, 2023, Volume: 17 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Ascorbic Acid; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Dopamine; Fluoxetine; Gabapentin; Hydroxyindoleacetic Acid; Mice; Serotonin	2023